Interferon alpha on NZM2328.Lc1R27: Enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure

Clinical Immunology

Volumn 154, Issue 1, 2014, Pages 66-71

  Dai, Chao ^a   Wang, Hongyang ^a   Sung, Sun Sang J ^a   Sharma, Rahul ^a   Kannapell, Carol ^a   Han, Wei ^a   Wang, Qian ^a   Davidson, Anne ^b   Gaskin, Felicia ^a   Fu, Shu Man ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Interferon ; Mouse model for lupus nephritis; SLE

Indexed keywords

ALBUMIN; ALPHA INTERFERON; AUTOANTIBODY; CREATININE; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL INFILTRATION; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; GLOMERULUS; IMMUNE COMPLEX DEPOSITION; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; UREA NITROGEN BLOOD LEVEL;

INTERFERON Α; MOUSE MODEL FOR LUPUS NEPHRITIS; SLE;

ADENOVIRIDAE; ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS; INTERFERON-ALPHA; KIDNEY; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE;

EID: 84904260556     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.06.008     Document Type: Article

References (15)

1. Tsokos G.C. Systemic lupus erythematosus. N. Engl. J. Med. 2011, 365:2110-2121. 10.1056/NEJMra1100359.
2. Hooks J.J., Moutsopoulos H.M., Geis S.A., Stahl N.I., Decker J.L., Notkins A.L. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 1979, 301:5-8.
3. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., Gregersen P.K., Behrens T.W. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2610-2615. (PMC151388).
4. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003, 197:711-723. (PMC2193846).
5. Elkon K.B., Wiedeman A. Type I IFN system in the development and manifestations of SLE. Curr. Opin. Rheumatol. 2012, 24:499-505. 10.1097/BOR.0b013e3283562c3e.
6. Lauwerys B.R., Ducreux J., Houssiau F.A. Type I interferon blockade in systemic lupus erythematosus: where do we stand?. Rheumatology (Oxford) Dec 15 2013, (Epub ahead of print). 10.1093/rheumatology/ket403.
7. Ioannou Y., Isenberg D.A. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum. 2000, 43:1431-1442.
8. Landolt-Marticorena C., Bonventi G., Lubovich A., Ferguson C., Unnithan T., Su J., Gladman D.D., Urowitz M., Fortin P.R., Wither J. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann. Rheum. Dis. 2009, 68:1440-1446. 10.1136/ard.2008.093146.
9. Petri M., Singh S., Tesfasyone H., Dedrick R., Fry K., Lal P.G., Williams G., Bauer J.W., Gregersen P.K., Behrens T.W., Baechler E.C. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 2009, 18:980-989. 10.1177/0961203309105529.
10. Waters S.T., Fu S.M., Gaskin F., Deshmukh U.S., Sung S.-S.J., Kannapell C.C., Tung K.S.K., McEwen S.B., McDuffie M. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin. Immunol. 2001, 100:372-383.
11. Waters S.T., McDuffie M., Bagavant H., Deshmukh U.S., Gaskin F., Jiang C., Tung K.S.K., Fu S.M. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J. Exp. Med. 2004, 199:255-264. (PMCID: PMC2211766).
12. Ge Y., Jiang C., Sung S.-S.J., Bagavant H., Dai C., Wang H., Kannapell C.C., Cathro H.P., Fu S.M. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J. Exp. Med. 2013, 210:2387-2401. (PMC3804943). 10.1084/jem.20130731.
13. Liu Z., Bethunaickan R., Huang W., Lodhi U., Solano I., Madaio M.P., Davidson A. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner. Arthritis Rheum. 2011, 63:219-229. (PMC3014995). 10.1002/art.30087.
14. Jacob N., Guo S., Mathian A., Koss M.N., Gindea S., Putterman C., Jacob C.O., Stohl W. B cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J. Immunol. 2011, 186:4984-4993. (PMC3074466). 10.4049/jimmunol.1000466.
15. Zhao J., Wang H., Dai C., Wang H., Zhang H., Huang Y., Wang S., Gaskin F., Fu S.M. P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway. Arthritis Rheum. 2013, 65:3176-3185. (PMC4038356). 10.1002/art.38174.